Skip to Main Content

Paper Details

Comparative cardiovascular safety of strontium ranelate and bisphosphonates: a multi-database study in 5 EU countries by the EU-ADR Alliance.
Osteoporos Int
9
2020
AMI, BP, CVDeath, Strontium ranelate, VTE, acute myocardial infarction, bisphosphonate, bisphosphonates, cardiac and thromboembolic events, cardiovascular death, patients, strontium ranelate, venous thromboembolism
Author NameAffiliation
Peter R RijnbeekErasmus University Medical Center
Peter R RijnbeekErasmus University Medical Center
Carlen ReyesIdiap Jordi Gol Primary Care Research Institute and CIBERFes, Universitat Autonoma de Barcelona and Instituto de Salud Carlos III
Johan van der LeiErasmus University Medical Center
Johan van der LeiErasmus University Medical Center
Miriam C J M SturkenboomUniversity Medical Center
Daniel Prieto-AlhambraUniversity of Oxford
Daniel Prieto-AlhambraIdiap Jordi Gol Primary Care Research Institute and CIBERFes, Universitat Autonoma de Barcelona and Instituto de Salud Carlos III
Daniel Prieto-AlhambraUniversity of Oxford
Daniel Prieto-AlhambraIdiap Jordi Gol Primary Care Research Institute and CIBERFes, Universitat Autonoma de Barcelona and Instituto de Salud Carlos III
  • 1 - 10

Datasets

Release 1.2